Motor function performance in individuals with RYR1-related myopathies

被引:6
|
作者
Witherspoon, Jessica W. [1 ]
Vuillerot, Carole [2 ,3 ,4 ]
Vasavada, Ruhi P. [5 ]
Waite, Melissa R. [5 ]
Shelton, Monique [1 ]
Chrismer, Irene C. [1 ]
Jain, Minal S. [5 ]
Meilleur, Katherine G. [1 ]
机构
[1] NINR, NIH, Bethesda, MD 20892 USA
[2] Hosp Civils Lyon, Hop Femme Mere Enfant, Escale, Serv Med Phys & Readaptat Pediat, F-69500 Bron, France
[3] Univ Lyon, F-69000 Lyon, France
[4] Univ Lyon 1, F-69100 Villeurbanne, France
[5] NIH, Rehabil Med, Bldg 10, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
disease progression; GFT; MFM; motor function; RYR1; DUCHENNE MUSCULAR-DYSTROPHY; CONGENITAL MYOPATHIES; RYR1;
D O I
10.1002/mus.26491
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction The objective of this study was to obtain a 6-month natural history of motor function performance in individuals with RYR1- related myopathy (RYR1-RM) by using the Motor Function Measure-32 (MFM-32) and graded functional tests (GFT) while facilitating preparation for interventional trials. Methods In total, 34 participants completed the MFM-32 and GFTs at baseline and 6-month visits. Results Motor deficits according to MFM-32 were primarily observed in the standing and transfers domain (D1; mean 71%). Among the GFTs, participants required the most time to ascend/descend stairs (>7.5 s). Functional movement, determined by GFT grades, was strongly correlated with MFM-32 (D1; r >= 0.770, P < 0.001). Motor Function Measure-32 and GFT scores did not reflect any change in performance between baseline and 6-month visits. Discussion The MFM-32 and GFTs detected motor impairment in RYR1-RM, which remained stable over 6 months. Thus, these measures may be suitable for assessing change in motor function in response to therapeutic intervention. Muscle Nerve 60: 80-87, 2019
引用
收藏
页码:80 / 87
页数:8
相关论文
共 50 条
  • [21] 6-minute walk test as a measure of disease progression and fatigability in a cohort of individuals with RYR1-related myopathies
    Witherspoon, Jessica W.
    Vasavada, Ruhi P.
    Waite, Melissa R.
    Shelton, Monique
    Chrismer, Irene C.
    Wakim, Paul G.
    Jain, Minal S.
    Bonnemann, Carsten G.
    Meilleur, Katherine G.
    ORPHANET JOURNAL OF RARE DISEASES, 2018, 13
  • [22] 6-minute walk test as a measure of disease progression and fatigability in a cohort of individuals with RYR1-related myopathies
    Jessica W. Witherspoon
    Ruhi P. Vasavada
    Melissa R. Waite
    Monique Shelton
    Irene C. Chrismer
    Paul G. Wakim
    Minal S. Jain
    Carsten G. Bönnemann
    Katherine G. Meilleur
    Orphanet Journal of Rare Diseases, 13
  • [23] Randomized controlled trial of N-acetylcysteine therapy for RYR1-related myopathies
    Todd, Joshua J.
    Lawal, Tokunbor A.
    Witherspoon, Jessica W.
    Chrismer, Irene C.
    Razaqyar, Muslima S.
    Punjabi, Monal
    Elliott, Jeffrey S.
    Tounkara, Fatoumata
    Kuo, Anna
    Shelton, Monique O.
    Allen, Carolyn
    Cosgrove, Mary M.
    Linton, Melody
    Michael, Darren
    Jain, Minal S.
    Waite, Melissa
    Drinkard, Bart
    Wakim, Paul G.
    Dowling, James J.
    Bonnemann, Carsten G.
    Emile-Backer, Magalie
    Meilleur, Katherine G.
    NEUROLOGY, 2020, 94 (13) : E1434 - E1444
  • [24] Functional impairments, fatigue and quality of life in RYR1-related myopathies: A questionnaire study
    van Ruitenbeek, E.
    Custers, J. A. E.
    Verhaak, C.
    Snoeck, M.
    Erasmus, C. E.
    Kamsteeg, E. J.
    Schouten, M., I
    Coleman, C.
    Treves, S.
    van Engelen, B. G.
    Jungbluth, H.
    Voermans, N. C.
    NEUROMUSCULAR DISORDERS, 2019, 29 (01) : 30 - 38
  • [25] Therapies for RYR1-Related Myopathies: Where We Stand and the Perspec-tives
    Beaufils, Mathilde
    Travard, Lauriane
    Rendu, John
    Marty, Isabelle
    CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (01) : 15 - 25
  • [26] 6-Minute walk test as a fatigability measure in RYR1-related myopathies
    Witherspoon, J.
    Vasavada, R.
    Waite, M.
    Chrismer, I.
    Jain, M.
    Meilleur, K.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S239 - S239
  • [27] Pancreatitis in RYR1-related disorders
    Famili, D.
    Mistry, A.
    Treves, S.
    Tribe, R.
    Kyrana, E.
    Dhawan, A.
    Goldberg, M.
    Voermans, N.
    Willis, T.
    Jungbluth, H.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S127 - S127
  • [28] Pancreatitis in RYR1-related disorders
    Famili, Dennis T.
    Mistry, Arti
    Gerasimenko, Oleg
    Gerasimenko, Julia
    Tribe, Rachel M.
    Kyrana, Eirini
    Dhawan, Anil
    Goldberg, Michael F.
    Voermans, Nicol
    Willis, Tracey
    Jungbluth, Heinz
    NEUROMUSCULAR DISORDERS, 2023, 33 (10) : 769 - 775
  • [29] Gene therapy strategies using CRISPR/Cas9 for RyR1-related myopathies
    Beaufils, Mathilde
    Brocard, Julie
    Faure, Julien
    Rendu, John
    Marty, Isabelle
    BIOPHYSICAL JOURNAL, 2023, 122 (03) : 239A - 240A
  • [30] Individuals and Families Affected by RYR1-Related Diseases: The Patient/Caregiver Perspective
    van de Camp, Sanne A. J. H.
    Stinissen, Lizan
    Huseth, Andrew
    Simon, Brentney
    Ryan, Jennifer
    Sarkozy, Anna
    Van Petegem, Filip
    Goldberg, Michael F.
    Jungbluth, Heinz
    Bohm, Johann
    Oortwijn, Wija
    Dirksen, Robert T.
    Voermans, Nicol C.
    JOURNAL OF NEUROMUSCULAR DISEASES, 2024, 11 (05) : 1067 - 1083